参考文献/References:
[1].Bruschke AV,Sheldon WC,Shirey EK,et al. A half century of selective coronary arteriography[J]. J Am Coll Cardiol,2009,54(23):2139-2144.
[2].Levine GN,Bates ER,Blankenship JC,et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction:An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[J]. J Am Coll Cardiol,2016,67(10):1235-1250.
[3].徐南图. 冠心病诊断的难度(下)[J]. 心血管病防治知识,2008,10:18-19.
[4].中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.
[5].Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur H eart J,2019,40(2):87-165.
[6].刘金玉,闫子麒,游如旭,等. 145例三磷酸腺苷不良反应/事件报告分析[J]. 药学与临床研究,2016,24(3):253-256.
[7].Tu S,Westra J,Yang J,et al. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography:the international multicenter FAVOR pilot study[J]. JACC Cardiovasc Interv,2016,9(19):2024-2035.
[8].Lee SH,Choi KH,Lee JM,et al. Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization[J]. Catheter Cardiovasc Interv,2020,Jul 3. DOI: 10.1002/ccd.29118. Online ahead of print.
[9].Lauri FM,Macaya F,Mejía-Rentería H,et al. Angiography derived functional assessment of non-culprit coronary stenoses in primary percutaneous coronary intervention[J]. EuroIntervention,2020,15(18):e1594-e1601.
[10].Spitaleri G,Tebaldi M,Biscaglia S,et al. Quantitative flow ratio identifies nonculprit coronary lesions requiring revascularization in patients with st segment-elevation myocardial infarction and multivessel disease[J]. Circ Cardiovasc Interv,2018,11(2):e006023.
[11].[11] Qi Q,Liu G,Yuan Z,et al. Quantitative flow ratio-guided surgical intervention in symptomatic myocardial bridging[J]. Cardiol J,2020 Jan 7.DOI: 10.5603/CJ.a2019.0113.Online ahead of print.
[12].[12] Safi H,Bourantas CV,Ramasamy A,et al. Predictive value of the QFR in detecting vulnerable plaques in non-flow limiting lesions:a combined analysis of the PROSPECT and IBIS-4 study[J]. Int J Cardiovasc Imaging,2020,36(6):993-1002.
[13].[13] Buono A,Mühlenhaus A,Sch?fer T,et al. QFR predicts the incidence of long-term adverse events in patients with suspected CAD:feasibility and reproducibility of the method[J]. J Clin Med,2020,9(1):220.
[14].[14] Hamaya R,Hoshino M,Kanno Y,et al. Prognostic implication of three-vessel contrast-flow quantitative flow ratio in patients with stable coronary artery disease[J]. EuroIntervention,2019,15(2):180-188.
[15].[15] Sheng X,Qiao Z,Ge H,et al. Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2020,95 suppl 1:624-632.
[16].[16] Saito Y,Cristea E,Bouras G,et al. Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold[J]. Catheter Cardiovasc Interv,2020,Feb 20.DOI: 10.1002/ccd.28804.?Online ahead of print.
[17].[17] Asano T,Katagiri Y,Collet C,et al. Functional comparison between BuMA Supreme biodegradable polymer sirolimus-eluting and durable polymer zotarolimus-eluting coronary stents using quantitative flow ratio:PIONEER QFR substudy[J]. EuroIntervention,2018,14(5):e570-e579.
[18].[18] 车千秋,王琼英,梁宇博,等. 血管内超声与冠状动脉造影指导的经皮冠状动脉介入治疗左主干病变有效性和安全性的Meta分析[J]. 中国循证医学杂志,2020,20(1):71-78.
[19].[19] Bezerra CG,Hideo-Kajita A,Bulant CA,et al. Coronary fractional flow reserve derived from intravascular ultrasound imaging:validation of a new computational method of fusion between anatomy and physiology[J]. Catheter Cardiovasc Interv,2019,93(2):266-274.
[20].[20] Seike F,Uetani T,Nishimura K,et al. Intravascular ultrasound-derived virtual fractional flow reserve for the assessment of myocardial ischemia[J]. Circ J,2018,82(3):815-823.
[21].[21] 贾小伟,张蛟,刘惠亮. 光学相干断层扫描在冠状动脉介入中应用进展[J].武警医学,2014,25(11):1167-1170.
[22].[22] Tian F,Yu W,Huang J,et al. First presentation of integration of intravascular optical coherence tomography and computational fractional flow reserve [J]. Int J Cardiovasc Imaging,2019,35(4):601-602.
[23].[23] Yu W,Huang J,Jia D,et al. Diagnostic accuracy of intracoronary optical coherence tomography-derived fractional flow reserve for assessment of coronary stenosis severity[J]. EuroIntervention,2019,15(2):189-197.
[24].[24] Huang J,Emori H,Ding D,et al. Comparison of diagnostic performance of intracoronary optical coherence tomography-based and angiography-based fractional flow reserve for evaluation of coronary stenosis[J]. EuroIntervention,2020,16(7):568-576.
相似文献/References:
[1]赵航 汪立杰 金元哲.血流储备分数在冠心病特殊人群中的临床应用进展[J].心血管病学进展,2020,(12):1272.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.012]
ZHAO Hang,WANG L ijie,JIN Yuanzhe.Clinical Application Advances of Fractional Flow Reserve in Special Populations with Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2020,(3):1272.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.012]
[2]胥日,羊镇宇.冠状动脉非阻塞性心肌梗死的发病机制[J].心血管病学进展,2021,(2):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
XU Ri,YANG Zhenyu.Pathogenesis and Imaging Manifestations of Myocardial Infarction with Non-obstructive Coronary Arteries[J].Advances in Cardiovascular Diseases,2021,(3):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
[3]方杰 李春梅 林薿 苏叶 陈丽君 李爽 邓燕 尹立雪 吴志霞.心肌增强多巴酚丁胺负荷超声心动图定量评价冠心病心肌灌注的临床研究[J].心血管病学进展,2021,(8):742.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.017]
FANG Jie,LI Chunmei,LIN Ni,et al.Quantitative Evaluation of Myocardial Perfusion in Coronary Heart Disease by Myocardial Contrast and Dobutamine Stress Echocardiography[J].Advances in Cardiovascular Diseases,2021,(3):742.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.017]
[4]赵润涛 王凡 单冬凯 杨俊杰.CT心肌灌注概述及临床应用进展[J].心血管病学进展,2021,(12):1101.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.011]
ZHAO Runtao WANG Fan SHAN Dongkai?YANG Junjie.CT Myocardial Perfusion and Clinical Application[J].Advances in Cardiovascular Diseases,2021,(3):1101.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.011]
[5]蒋梦婷 张瑜 高磊.髓系细胞触发受体-1在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2023,(4):345.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.013]
JIANG Mengting,ZHANG Yu,GAO Lei.Triggering Receptor Expressed on Myeloid Cells-1 in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2023,(3):345.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.013]
[6]陈杰 常静 石秋月 陈月茗 李鑫 赵宏.钠-葡萄糖共转运蛋白2抑制剂治疗冠心病患者的疗效及作用机制[J].心血管病学进展,2023,(8):704.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.008]
CHEN Jie,CHANG Jing,SHI Qiuyue,et al.Therapeutic Effect and Mechanism of Sodium-Glucose Linked Transporter 2 Inhibitor in Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2023,(3):704.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.008]
[7]纪欣强 单冬凯 王凡 赵润涛 杨俊杰.CT及其衍生技术评价冠状动脉钙化病变的研究进展[J].心血管病学进展,2024,(3):229.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.009]
JI Xinqiang,SHAN Dongkai,WANG Fan,et al.Evaluation of Coronary Artery Calcification Using CT and Its Derivative Techniques[J].Advances in Cardiovascular Diseases,2024,(3):229.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.009]